Earnings Outlook For Xeris Biopharma Holdings

Xeris Biopharma Holdings XERS is gearing up to announce its quarterly earnings on Friday, 2024-11-08. Here's a quick overview of what investors should know before the release.

Analysts are estimating that Xeris Biopharma Holdings will report an earnings per share (EPS) of $-0.09.

The market awaits Xeris Biopharma Holdings's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.

It's important for new investors to understand that guidance can be a significant driver of stock prices.

Overview of Past Earnings

The company's EPS beat by $0.01 in the last quarter, leading to a 4.04% increase in the share price on the following day.

Here's a look at Xeris Biopharma Holdings's past performance and the resulting price change:

Tracking Xeris Biopharma Holdings's Stock Performance

Shares of Xeris Biopharma Holdings were trading at $3.34 as of November 06. Over the last 52-week period, shares are up 100.59%. Given that these returns are generally positive, long-term shareholders should be satisfied going into this earnings release.

To track all earnings releases for Xeris Biopharma Holdings visit their earnings calendar on our site.

This article was generated by Benzinga's automated content engine and reviewed by an editor.